BENOQUIN Drug Patent Profile
✉ Email this page to a colleague
When do Benoquin patents expire, and when can generic versions of Benoquin launch?
Benoquin is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in BENOQUIN is monobenzone. There are two drug master file entries for this compound. Additional details are available on the monobenzone profile page.
Summary for BENOQUIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 1,864 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BENOQUIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BENOQUIN
US Patents and Regulatory Information for BENOQUIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | BENOQUIN | monobenzone | CREAM;TOPICAL | 008173-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |